Home

Subscription

April 2024 issue

April 1, 2024 issue

March 2024 issue

February 2024 issue

January 2024 issue



BACK ISSUES

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006


2017 Issues

December 2017 Issue
• Feature: Blessings and Dreams

November 2017 Issue
• Feature: Some Pharmacists Still Sell Cigarettes – Such as Walgreens at the Congested Corner of Smokey and Sickly!
• New Drug Review: Voxilaprevir/sofosbuvir/velpatasvir (Vosevi)


October 2017 Issue
• Feature: The Independent Community Pharmacist Summit on Strategy, Structure, and Survival (ICPSSSS)
• New Drug Review: Glecaprevir/pibrentasvir (Mavyret)


September 2017 Issue
• Feature: Our Profession's Own Pharmacy Care Administrator (PCA): Part 5
• New Drug Review: Safinamide mesylate (Xadago)


August 2017 Issue
• Feature: Our Profession's Own Pharmacy Care Administrator (PCA): Part 4
• New Drug Review: Plecanatide (Trulance)


July 2017 Issue
• Feature: Our Profession's Own Pharmacy Care Administrator (PCA): Part 3
• New Drug Review: Crisaborole (Eucrisa)


June 2017 Issue
• Feature: Our Profession's Own Pharmacy Care Administrator (PCA): Part 2 - Honest, Simple, Clear, Fair, Transparent!
• New Drug Review: Ocrelizumab (Ocrevus)


May 2017 Issue
• Feature: Our Profession's Own Pharmacy Care Administrator (PCA): Can a Dream Become Reality?
• Table: New Therapeutic Agents Marketed in the United States in 2016


April 2017 Issue
• Feature: Hungarian-American Pharmacists Association (HAPA) Established!
• New Drug Review: FDA Approves Sale of Prescription Placebo


March 2017 Issue
• Feature: Many Walmart Customers Will Stop Smoking Today! Their Funerals Will Be Held Sometime in the Next Three or Four Days

February 2017 Issue
• Feature: Drug Interaction Investigation: Part 2 There Must be Mandatory Reporting of Serious Medication Errors and Prohibition of Confidentiality Agreements that Restrict Disclosure!
• New Drug Review: Patiromer sorbitex calcium (Veltassa)


January 2017 Issue
• Feature: Pharmacy FAILS Drug Interaction Investigation! Pharmacists: Be on Guard and Stand Your Ground Against Metrics!